Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew


IMPACT FACTOR 2017: 0.484
5-year IMPACT FACTOR: 0.484

CiteScore 2017: 0.53

SCImago Journal Rank (SJR) 2017: 0.154
Source Normalized Impact per Paper (SNIP) 2017: 0.264

ICV 2017: 152.94

Open Access
Online
ISSN
2391-5463
See all formats and pricing
More options …
Volume 6, Issue 2

Issues

Volume 10 (2015)

Isolation and antifungal sensitivity to Candida isolates in young females

Y. Adesiji / N. Ndukwe
  • Department of Biomedical Science, College of Health Sciences, Ladoke Akintola University of Technology, PMB, 4400, Osogbo, Nigeria
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ B. Okanlawon
  • Department of Biomedical Science, College of Health Sciences, Ladoke Akintola University of Technology, PMB, 4400, Osogbo, Nigeria
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2011-02-17 | DOI: https://doi.org/10.2478/s11536-010-0071-0

Abstract

A survey of 104 sexually active young females tested on on cervico-vaginal swabs showed that 26 of the females (25%) had vulvovaginal candidiasis with a species distribution of Candida isolates accounting for 13 (50%) with C. albicans, 6 (23%) with C. glabrata, 1 (4%) with C. krusei, and 6 (23%) with C. tropicalis. Of the 26 (25 %) subjects that were positive for VVC, 8 (7.8 %) were symptomatic and 18 (18.8 %) were asymptomatic. However, distribution among different age groups revealed an increase in the 23–27 age group. The comparative analysis of sensitivity of the given fungi to the number of antimycotic preparations used revealed the following: in fluconazole, 2 (7.8%) isolates were sensitive, 5 (19.2%) were susceptible and dose dependent, and 19 (73%) were resistant. For voriconazole, 4 (18.4%) isolates were sensitive, 6 (23.1%) were susceptible and dose dependent, and 16 (61.5%) were resistant. For nystatin, 5 (19.2%) isolates were sensitive, 10 (38.5%) were susceptible and dose dependent, and 11 (42.3%) were resistant. It appears that Candida isolates have a variable resistance response, but 19 (73%) had maximum resistance of the isolated fungi of the genus Candida to fluconazole. Therefore, further studies on the evaluation of combination therapy should be considered for a better outcome in treatment of vulvovaginal candidiasis.

Keywords: Candidiasis epidemiology; Young Female; Antifungal Sensitivity Tests; Nigeria

  • [1] Nwokedi E, Omole-Ohonsi A (2007): Current Clinical Review of Vulvovaginal Candidiasis (VVC). Journal of Medicine and Rehabilitation: 1: 28–32 Google Scholar

  • [2] Onifade AK, Olorunfemi OB (2005): Epidemiology of Vulvo-vaginal Candidiasis in Female Patients in Ondo State Government Hospitals. International Journal of Food, Agriculture and Environment: 3: 118–119 Google Scholar

  • [3] Sexually transmitted diseases treatment guidelines (2006): Centers for Disease Control and Prevention. MMWR Recomm. Rep. 55(RR-11): 1–95 Google Scholar

  • [4] Sobel J, Chaim W, Nagappan V, Leaman D (2003): Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol 189: 1:297–300 http://dx.doi.org/10.1067/S0002-9378(03)00726-9CrossrefGoogle Scholar

  • [5] Sobel JD (1998): Vulvovaginitis due to Candida glabrata. An emerging problem. Mycoses 41(suppl. 2): 18–22 http://dx.doi.org/10.1111/j.1439-0507.1998.tb00594.xCrossrefGoogle Scholar

  • [6] Gygax S.E, Vermitsky JP, Chadwick SG, JS Matthew, J A. Zimmerman, E Mordechai, M E. Adelson, 3 and J P. Trama: Antifungal Resistance of Candida glabrata, Vaginal Isolates, and Development of a Quantitative Reverse Transcription-PCR-Based Azole Susceptibility Assay Antimicrobial Agents and Chemotherapy, 2008: 52(9): 3424–3426 Web of ScienceGoogle Scholar

  • [7] Ribeiro M, Dietze R, Paula C, Da-Matta D, Colombo A (2000): Susceptibility profile of vaginal yeast isolates from Brazil. Mycopathologia 15: 5–10 Google Scholar

  • [8] Arthington-Skaggs B, Motley M, Warnocks D, Morrison C (2000): Comparative Evaluation of PASCO and National Committee for Clinical Laboratory Standards M-27-A Broth Microdilution Methods for Antifungal Drug Susceptibility Testing of Yeast. J. Clin. Microbiol. 38: 2254–2260. Google Scholar

  • [9] Clinical Laboratory Standards Institute (2007): Reference Method for Disc diffusion Antifungal Susceptibility of yeasts Approved standard M-44-A. CLSI, Villanova, PA, USA Google Scholar

  • [10] Howard L (1991): Epidemiology of Vagintis. American journal of Obstetrics and Gynaecology, 165: 1168–1176 Google Scholar

  • [11] Enweani IB, Ogbonna CI, Kozak W (1987): The incidence of candidiasis amongst the asymptomatic female students of the University of Jos, Nigeria. Mycopathologia. 99: 123–141 http://dx.doi.org/10.1007/BF00437435CrossrefGoogle Scholar

  • [12] Ako-Nai AK, Kassim OO, Adeniram MO, Taiwo O (1993): A study of urinary tract infections at Ile lfe, Nigeria. East African Med J. 70: 19–14 Google Scholar

  • [13] Vermitsky JP, J Matthew. G. S. Sean. J. P. Chadwick. M. E Trama, A, E Mordechai and S.E. Gygax (2009): A Survey of Vaginal-flora Candida species of Different Age Groups Using species-specific PCR Detection. J. Clin. Microbiol. doi:10.1128/JCM.02485-07 CrossrefGoogle Scholar

  • [14] Watson C and Calabretto H (2007): Comprehensive review of conventional and non-conventional methods of management of recurrent vulvovaginal candidiasis. Austr. J Obstet Gynecol. 47: 262–272 http://dx.doi.org/10.1111/j.1479-828X.2007.00736.xCrossrefGoogle Scholar

  • [15] Solanki A, Mathur D, Joshi K (1983): Bacterial, fungal and parasitic flora in vaginitis. J Indian Med Assoc 1983; 81: 151–153 Google Scholar

  • [16] Holland J, Young M, Lee O, Chen S (2003): Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect 2003; 79: 249–250 http://dx.doi.org/10.1136/sti.79.3.249CrossrefGoogle Scholar

  • [17] McCormack WM, Starko KM, Zinne SH (1998): Symptoms associated with vaginal colonization with yeast. Am. J. Obstet. Gynecol. 158: 31–33 Google Scholar

  • [18] Enweani IB, Gugnani H, Okobia R, Roseline Okobia, Ojo SB (2001). Effects of contraceptives on the prevalence of vaginal colonization with Candida species in Edo State. Microbiol 18: 171–173 Google Scholar

  • [19] Kikani BA, Kikani KM, Pathak SJ (2008): Effects of chemically synthesized azole compounds on clinical isolates of Vaginal Candidiasis, in comparison with commercially available drugs. The internet journal of Microbiology. 4–2 Google Scholar

  • [20] Okungbowa FI, Isikhumhen SO, Dede PO (2003): The distribution frequency of Candida species in the genitourinary tract among symptomatic individuals in Nigerian Cities. Micrologia 20: 60–63 Google Scholar

  • [21] Koutsoukou A, Stylianakis A, Tsiplakou S, Tachtatzis M., Tsakona E., Vourtsi A., Sideri A (2005): A 3-year study of resistance of candida pathogens obtained from patients with fungemia with emphasis to new antifungal agents. Athens Med J. p 1228 Google Scholar

  • [22] Cruz O, (2003): Species distribution and antifungal susceptibility profile of Candida spp. Bloodstream isolates from Latin American Hospitals. J. Clin. Microbiol; 98: 401–5 Google Scholar

  • [23] Ferris D, Nyorjesy P, Sobel J, Soper D, Pavletio A, Litaker M (2002): Over the counter antifungal drug misuse associated with patient diagnosed vulvovaginal candidiasis. Obstet Gynecool: 99: 419–425 http://dx.doi.org/10.1016/S0029-7844(01)01759-8CrossrefGoogle Scholar

About the article

Published Online: 2011-02-17

Published in Print: 2011-04-01


Citation Information: Open Medicine, Volume 6, Issue 2, Pages 172–176, ISSN (Online) 2391-5463, DOI: https://doi.org/10.2478/s11536-010-0071-0.

Export Citation

© 2011 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Ali Ghajari, Ensieh Lotfali, Nayeb Ali Ahmadi, Parvin Nazer Fassihi, Nasrin Shahmohammadi, Saham Ansari, Maryam Norouzi, and Zahra Arab-Mazar
Archives of Clinical Infectious Diseases, 2018, Volume In Press, Number In Press
[2]
Mohammad Taghi Hedayati, Zahra Taheri, Tahereh Galinimoghadam, Seyed Reza Aghili, Jamshid Yazdani Cherati, and Elham Mosayebi
Jundishapur Journal of Microbiology, 2015, Volume 8, Number 4

Comments (0)

Please log in or register to comment.
Log in